Inhalational use of antithrombotics in humans: Review of the literature.

[1]  P. Monagle,et al.  Topical use of antithrombotics: review of literature. , 2015, Thrombosis research.

[2]  M. Schroth,et al.  Use of Aerosolized Tissue Plasminogen Activator in the Treatment of Plastic Bronchitis , 2013, The Annals of pharmacotherapy.

[3]  G. Pongiglione,et al.  Plastic bronchitis after extracardiac Fontan operation. , 2012, The Annals of thoracic surgery.

[4]  T. Baglin,et al.  Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[5]  Paolo Prandoni,et al.  Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[6]  Jason C. Fish,et al.  Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[7]  Lian Yee Yip,et al.  Safety and potential anticoagulant effects of nebulised heparin in burns patients with inhalational injury at Singapore General Hospital Burns Centre. , 2011, Burns : journal of the International Society for Burn Injuries.

[8]  Sharon Calaman,et al.  A case report of clinically significant coagulopathy associated with aerosolized heparin and acetylcysteine therapy for inhalation injury. , 2011, Burns : journal of the International Society for Burn Injuries.

[9]  O. Wilander,et al.  The Influence of Intravenous Injections of Heparin in Man on the Time of Coagulation.1 , 2009 .

[10]  N. Anas,et al.  Fontan Patient with Plastic Bronchitis Treated Successfully Using Aerosolized Tissue Plasminogen Activator: A Case Report and Review of the Literature , 2009, Pediatric Cardiology.

[11]  Andrew C. Miller,et al.  Influence of Nebulized Unfractionated Heparin and N-Acetylcysteine in Acute Lung Injury After Smoke Inhalation Injury , 2009, Journal of burn care & research : official publication of the American Burn Association.

[12]  Clifford W Colwell,et al.  Prevention of Venous Thromboembolism* American College of Chest Physicians Evidence- Based Clinical Practice Guidelines (8th Edition) , 2008 .

[13]  B. Dixon,et al.  A phase 1 trial of nebulised heparin in acute lung injury , 2008, Critical care.

[14]  M. Spannagl,et al.  Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects. , 2007, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[15]  J. Conway,et al.  Inhaled heparin in cystic fibrosis , 2006, European Respiratory Journal.

[16]  P. Monagle,et al.  Developmental haemostasis , 2006, Thrombosis and Haemostasis.

[17]  Andrew H Van Bergen,et al.  Long-term treatment of plastic bronchitis with aerosolized tissue plasminogen activator in a Fontan patient , 2005, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[18]  S. Idell.  Coagulation, fibrinolysis, and fibrin deposition in acute lung injury , 2003, Critical care medicine.

[19]  J. Weiler,et al.  Does heparin prophylaxis prevent exacerbations of hereditary angioedema? , 2002, The Journal of allergy and clinical immunology.

[20]  K. E. Bendstrup,et al.  Effect of inhaled heparin on lung function and coagulation in healthy volunteers , 2002, European Respiratory Journal.

[21]  S. McColley,et al.  Treatment of plastic bronchitis in a Fontan patient with tissue plasminogen activator: a case report and review of the literature. , 2002, Pediatrics.

[22]  S. Atiş,et al.  Effects of Heparin on Hypertonic Potassium Chloride—Induced Bronchoconstriction , 2001, The Annals of pharmacotherapy.

[23]  A. Vatrella,et al.  Effect of inhaled heparin on water-induced bronchoconstriction in allergic asthmatics , 2001, European Journal of Clinical Pharmacology.

[24]  T. Çelikel,et al.  Effect of inhaled low molecular weight heparin on methacholine-induced bronchoconstriction. , 2000, International journal of clinical pharmacology and therapeutics.

[25]  M. Quasney,et al.  Plastic bronchitis occurring late after the Fontan procedure: Treatment with aerosolized urokinase , 2000, Critical care medicine.

[26]  K. E. Bendstrup,et al.  Inhaled heparin is effective in exacerbations of asthma. , 2000, Respiratory medicine.

[27]  K. E. Bendstrup,et al.  Lung deposition and clearance of inhaled (99m)Tc-heparin in healthy volunteers. , 1999, American journal of respiratory and critical care medicine.

[28]  T. Ahmed,et al.  Prevention of exercise-induced bronchoconstriction by inhaled low-molecular-weight heparin. , 1999, American journal of respiratory and critical care medicine.

[29]  D. Herndon,et al.  Reduction in mortality in pediatric patients with inhalation injury with aerosolized heparin/acetylcystine therapy , 1998 .

[30]  T. Çelikel,et al.  Effect of inhaled heparin on adenosine-induced bronchial hyperreactivity. , 1997, International journal of clinical pharmacology and therapeutics.

[31]  A. Mistretta,et al.  Time course of changes in adenosine 5'-monophosphate airway responsiveness with inhaled heparin in allergic asthma. , 1997, The Journal of allergy and clinical immunology.

[32]  J. Harenberg,et al.  Anticoagulant effects and tissue factor pathway inhibitor after intrapulmonary low‐molecular‐weight heparin , 1996, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[33]  P. Sterk,et al.  Effect of inhaled heparin on allergen-induced early and late asthmatic responses in patients with atopic asthma. , 1996, American journal of respiratory and critical care medicine.

[34]  T. Ahmed,et al.  Time course of the protective effect of inhaled heparin on exercise-induced asthma. , 1996, American journal of respiratory and critical care medicine.

[35]  I. Pavord,et al.  The effect of inhaled heparin on bronchial reactivity to sodium metabisulphite and methacholine in patients with asthma. , 1996, The European respiratory journal.

[36]  T. Çelikel,et al.  Effect of inhaled heparin on methacholine-induced bronchial hyperreactivity. , 1995, Chest.

[37]  V. Efimov,et al.  Administration of heparin inhalations for correction of blood antithrombin activity in pregnant women with IDDM , 1995, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[38]  T. Ahmed,et al.  Preventing bronchoconstriction in exercise-induced asthma with inhaled heparin. , 1993, The New England journal of medicine.

[39]  J. Nawrot,et al.  Morning vs evening effects of intrapulmonary administration of heparin in healthy men. , 1992, International journal of clinical pharmacology, therapy, and toxicology.

[40]  D. W. Murray,et al.  Heparin and the thrombosis of veins following injury , 1937 .

[41]  B. Latenser.  Use of Inhaled Heparin/N-acetylcystine in Inhalation Injury: Does it help? , 2009 .

[42]  L. Kirchner,et al.  A Case of Plastic Bronchitis Presenting 9 Years After Fontan , 2007, Pediatric Cardiology.

[43]  P. Kuna,et al.  The effect of inhaled heparin on airway responsiveness to histamine and leukotriene D4. , 2003, Allergy and asthma proceedings.

[44]  D. Herndon,et al.  Reduction in mortality in pediatric patients with inhalation injury with aerosolized heparin/N-acetylcystine [correction of acetylcystine] therapy. , 1998, Journal of Burn Care and Rehabilitation.

[45]  S. Saryal,et al.  Effect of pretreatment with heparin on pulmonary and cutaneous response. , 1997, The Journal of asthma : official journal of the Association for the Care of Asthma.

[46]  S. Scheidt,et al.  History of drugs for thrombotic disease. Discovery, development, and directions for the future. , 1994, Circulation.

[47]  S. Gruber,et al.  Heparin as a therapy for atherosclerosis: preliminary observations on the intrapulmonary administration of low-dose heparin in the morning versus evening gauged by its effect on blood variables. , 1991, Chronobiology international.

[48]  P. Psuja,et al.  Nebulized heparin and anabolic steroid in the prevention of postoperative deep vein thrombosis following elective abdominal surgery. , 1990, Folia haematologica.